Skip to content
Intrommune Therapeutics
  • About Us
  • Our Science
    • Overview
    • Peanut/Tree Nut INT302
  • News & Resources
  • Blog
  • Contact
Intrommune Therapeutics

Intrommune

Intrommune Therapeutics Strikes Deal with Circuit Clinical®

Press Releases / By Intrommune

Keiretsu Investor Capital Forum

Events / By Intrommune

Recent Peer-Reviewed Publication Supports Immunotherapy for the Treatment of Food Allergies

Press Releases / By Intrommune

Angel Venture Fair

Events / By Intrommune

BIONJ BioPartnering Conference 2020

Events / By Intrommune

Media Alert: Interest in Peanut Allergy Market Heats up in the Wake of Aimmune/Nestlé Deal

Press Releases / By Intrommune

Senior Medical Advisor, William Reisacher, interviewed on the Price of Business with Kevin Price

In the News / By Intrommune

Survey Confirms Physician Interest in Peanut Allergy Immunotherapy

Press Releases / By Intrommune

Proactive Interview: Intrommune Therapeutics moving its peanut allergy treatment through the FDA approval process

In the News / By Intrommune

Intrommune Presenting at Biotech Showcase 2020

Press Releases / By Intrommune
Posts pagination
← Previous Page 1 … 5 6 7 Next Page →
  • About Us
  • Our Science
    • Overview
    • Peanut/Tree Nut INT302
  • News & Resources
  • Blog
  • Contact
  • About Us
  • Our Science
  • Peanut/Tree Nut INT302
  • News & Resources
  • Contact

Sign up for Intrommune's newsletter and stay informed of company developments.


Intrommune
  • About Us
  • Our Science
  • Peanut/Tree Nut INT302
  • News & Resources
  • Contact

Sign up for Intrommune's newsletter and stay informed of company developments.


Copyright © 2025 Intrommune Therapeutics | Privacy Policy | Accessibility Statement